Literature DB >> 16084861

Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility.

Marco Filicori1, Asgerally T Fazleabas, Ilpo Huhtaniemi, Peter Licht, Ch V Rao, Jan Tesarik, Marek Zygmunt.   

Abstract

OBJECTIVE: To extensively review the scientific literature on the potential sites of hCG action and the role of this hormone on reproductive processes not necessarily related to the classic hCG functions of supporting early pregnancy.
DESIGN: Review of the international scientific literature and the authors' personal research experience in this area. RESULT(S): The LH/hCG receptor has an almost ubiquitous distribution in reproductive organs, thus suggesting that the actions of hCG might be more extensive than previously thought. Independently of FSH, low-dose hCG can support development and maturation of larger ovarian follicles that have acquired granulosa cells LH/hCG receptors, potentially providing effective and safer ovulation induction regimens. Human chorionic gonadotropin seems to be capable of improving uterine receptivity by enhancing endometrial quality and stromal fibroblast function. Furthermore, through its actions on insulin-like growth factor binding protein-1 and vascular endothelial growth factor, hCG might stimulate endometrial angiogenesis and growth and extend the implantation window, thus making pregnancy more likely. CONCLUSION(S): Mounting evidence indicates that hCG could be mediating relevant actions enhancing fertility and the efficacy of therapeutic procedures used in the management of infertility. Greater understanding of the physiologic roles that hCG plays in human reproduction might suggest novel clinical applications for this traditional hormone of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084861     DOI: 10.1016/j.fertnstert.2005.02.033

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  36 in total

1.  Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice.

Authors:  L-Y Khil; H-S Jun; H Kwon; J K Yoo; S Kim; A L Notkins; J-W Yoon
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

Review 2.  The role of chorionic gonadotropin and Notch1 in implantation.

Authors:  Yalda Afshar; Adina Stanculescu; Lucio Miele; Asgerally T Fazleabas
Journal:  J Assist Reprod Genet       Date:  2007-07       Impact factor: 3.412

3.  Human chorionic gonadotropin induces decidualization of ectopic human endometrium more effectively than forskolin in an in-vivo endometriosis model.

Authors:  Yvonne Koch; Pauline Wimberger; Ruth Grümmer
Journal:  Exp Biol Med (Maywood)       Date:  2018-06-09

Review 4.  Endometrial responses to embryonic signals in the primate.

Authors:  Prajna Banerjee; Asgerally T Fazleabas
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

5.  Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol.

Authors:  Kyono Koichi; Nakajo Yukiko; Kumagai Shima; Sasaki Sachiko
Journal:  J Assist Reprod Genet       Date:  2006-06-20       Impact factor: 3.412

6.  Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols.

Authors:  D Carone; C Caropreso; A Vitti; R Chiappetta
Journal:  J Endocrinol Invest       Date:  2012-10-22       Impact factor: 4.256

7.  Human choriogonadotropin prior to controlled ovarian stimulation and in vitro fertilization improves implantation, and pregnancy rates.

Authors:  Eduardo L Motta; Gary D Smith; Paulo C Serafini; Marcio Coslovsky; Pericles Hassun; Andre M Rocha; Isaac Yadid
Journal:  J Assist Reprod Genet       Date:  2009-06-16       Impact factor: 3.412

Review 8.  Gonadotropins in doping: pharmacological basis and detection of illicit use.

Authors:  U-H Stenman; K Hotakainen; H Alfthan
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

9.  Prokineticin 1 mediates fetal-maternal dialogue regulating endometrial leukemia inhibitory factor.

Authors:  Jemma Evans; Rob D Catalano; Pamela Brown; Rob Sherwin; Hilary O D Critchley; Asgerally T Fazleabas; Henry N Jabbour
Journal:  FASEB J       Date:  2009-03-02       Impact factor: 5.191

10.  "hCG priming" effect in controlled ovarian stimulation through a long protocol.

Authors:  Panagiotis Beretsos; George A Partsinevelos; Eleni Arabatzi; Peter Drakakis; Depy Mavrogianni; Elli Anagnostou; Kostas Stefanidis; Aris Antsaklis; Dimitris Loutradis
Journal:  Reprod Biol Endocrinol       Date:  2009-08-31       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.